We believe that to make change in the world, we have to do more than just dream big — we must have the courage to defy expectations and challenge the status quo. Since 2003, we’ve been doing just that, with a vision to be essential in the #CancerCommunity. https://lnkd.in/dUfQvRry
PharmaEssentia
Biotechnology Research
Nangang District, Taipei 10,256 followers
Better Science, Better Lives.
About us
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing, fully integrated global biopharmaceutical innovator. Leveraging proven scientific principles and deep expertise in commercializing medicines, the company aims to deliver biologics for challenging diseases in hematology, oncology and immunology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global presence with operations in the U.S., Japan, China and Korea. See our community guidelines: http://bit.ly/3RpFpn3
- Website
-
http://www.pharmaessentia.com
External link for PharmaEssentia
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Nangang District, Taipei
- Type
- Public Company
- Founded
- 2003
- Specialties
- Biologics, Oncology, Rare Disease, Orphan Drugs, Orphan Disease, Drug Development, Pharmaceuticals, and Hematology
Locations
Employees at PharmaEssentia
Updates
-
#PolycythemiaVera is a chronic and life-threatening #BloodCancer that arises from a single mutated stem cell. It’s rare enough that many have never heard of it before. Get the facts about #PV: http://bit.ly/3KlXK47 #RareDisease #BloodCancer
-
Today, we announced the appointment of Beth A. Krewson as Head of Legal at PharmaEssentia. In her new role, Beth will be responsible for the legal and compliance strategy to advance our leadership in MPNs and other hematological diseases. Learn more: https://bit.ly/4cNctAg
-
-
Know the facts about polycythemia vera (PV) and learn more about our focus on providing new therapeutic options for patients with #MPNs: https://lnkd.in/gMqBgEXg
-
In the latest episode of “PV Pod: Stories from the Marrow,” Dr. Douglas Tremblay from Mount Sinai School of Medicine discusses #PolycythemiaVera (PV) progression and the challenges in predicting and preventing this #RareDisease. Listen to PV Pod here: https://lnkd.in/eE99jZqv
-
-
Today, we announced the promotion of Robert B Geller, MD to General Manager. Dr. Geller will be responsible for expanding our pipeline and partnerships and capabilities in the U.S. to advance therapeutic options and care for patients. https://lnkd.in/ep6P_S5T
-
-
Know the facts about polycythemia vera (PV) and learn more about our focus on providing new therapeutic options for patients with #MPNs: https://bit.ly/40TXfDh
-
PharmaEssentia has completed patient enrollment for our Phase 2b EXCEED-ET trial and Phase 3b ECLIPSE-PV trial. Learn more: https://lnkd.in/dsjfKsk9 #PolycythemiaVera #EssentialThrombocythemia
-
-
Today, we announced the appointment of Fred P. as Head of Commercial at PharmaEssentia. In his new role, Fred will lead the commercial teams, including sales, marketing, and analytics. Learn more: https://lnkd.in/eqrGW-68
-